Omega Therapeutics Statistics

Total Valuation

OMGA has a market cap or net worth of $57.36 million. The enterprise value is $138.46 million.

Market Cap	57.36M
Enterprise Value	138.46M

Important Dates

The next estimated earnings date is Monday, November 11, 2024, before market open.

Earnings Date	Nov 11, 2024
Ex-Dividend Date	n/a

Share Statistics

OMGA has 55.15 million shares outstanding. The number of shares has increased by 9.44% in one year.

Shares Outstanding	55.15M
Shares Change (YoY)	+9.44%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	1.97%
Owned by Institutions (%)	32.86%
Float	21.33M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.09
Forward PS	18.30
PB Ratio	2.18
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	21.93
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.19, with a Debt / Equity ratio of 4.83.

Current Ratio	2.19
Quick Ratio	1.82
Debt / Equity	4.83
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-44.77

Financial Efficiency

Return on equity (ROE) is -129.15% and return on invested capital (ROIC) is -27.41%.

Return on Equity (ROE)	-129.15%
Return on Assets (ROA)	-25.37%
Return on Capital (ROIC)	-27.41%
Revenue Per Employee	$67,170
Profits Per Employee	-$839,319
Employee Count	94
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -42.54% in the last 52 weeks. The beta is 1.84, so OMGA's price volatility has been higher than the market average.

Beta (5Y)	1.84
52-Week Price Change	-42.54%
50-Day Moving Average	1.24
200-Day Moving Average	2.30
Relative Strength Index (RSI)	40.88
Average Volume (20 Days)	418,048

Short Selling Information

The latest short interest is 6.03 million, so 10.93% of the outstanding shares have been sold short.

Short Interest	6.03M
Short Previous Month	5.61M
Short % of Shares Out	10.93%
Short % of Float	28.27%
Short Ratio (days to cover)	31.09

Income Statement

In the last 12 months, OMGA had revenue of $6.31 million and -$78.90 million in losses. Loss per share was -$1.43.

Revenue	6.31M
Gross Profit	-39.48M
Operating Income	-80.63M
Pretax Income	-78.90M
Net Income	-78.90M
EBITDA	-78.89M
EBIT	-80.63M
Loss Per Share	-$1.43

Full Income Statement

Balance Sheet

The company has $45.85 million in cash and $126.95 million in debt, giving a net cash position of -$81.10 million or -$1.47 per share.

Cash & Cash Equivalents	45.85M
Total Debt	126.95M
Net Cash	-81.10M
Net Cash Per Share	-$1.47
Equity (Book Value)	26.26M
Book Value Per Share	0.48
Working Capital	30.52M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$64.60 million and capital expenditures -$2.77 million, giving a free cash flow of -$67.37 million.

Operating Cash Flow	-64.60M
Capital Expenditures	-2.77M
Free Cash Flow	-67.37M
FCF Per Share	-$1.22

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,277.07%
Pretax Margin	-1,249.54%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-1,056.70%

Dividends & Yields

OMGA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.44%
Shareholder Yield	-9.44%
Earnings Yield	-137.54%
FCF Yield	-117.45%

Analyst Forecast

The average price target for OMGA is $10.20, which is 880.77% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.20
Price Target Difference	880.77%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	126.59%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

OMGA has an Altman Z-Score of -3.7 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.7
Piotroski F-Score	3